版本:
中国

BRIEF-Novavax reschedules 4th annual investor, analyst meeting

Oct 7 Novavax Inc :

* Continue to analyze data from resolve clinical trial, map out clinical path forward for older adult RSV F vaccine

* Novavax reschedules 4th annual investor and analyst meeting Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐